PBLA stock is a buy, Roth says
Following some good news for the company, Roth MKM analyst Jonathan Aschoff has maintained his “Buy” rating on Panbela Therapeutics.
Source: cantechletter.com
Page 3 - Jonathan Aschoff News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jonathan Aschoff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jonathan Aschoff Today - Breaking & Trending Today
Arizona Biotech Advances Multiple Cell Therapies
Arizona Biotech Advances Multiple Cell Therapies
Source: investorideas.com
TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the TFF Pharmaceuticals Third Quarter 2023 Corporate Update and Earnings Conference Call.
Source: insidermonkey.com
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Cyclacel Pharmaceuticals Third Quarter 2023 Results Conference Call and Webcast. [Operator Instructions] Please note, today's call is being recorded.
Source: insidermonkey.com
Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q3 2023 Earnings Call Transcript
Operator: Good day, everyone. My name is Chelsea, and I will be your conference operator.
Source: insidermonkey.com